GLPwatch
Papers (12034)
Page 200 of 201, ranked by citation count.
- Pharmacokinetic Characteristics of a Once-Weekly Combination Therapy of Insulin Icodec and Semaglutide Versus Its Separate Components in Chinese Individuals with Type 2 Diabetes.
- Improved quality of life with semaglutide in schizophrenia: Secondary analyses from a randomized controlled trial.
- Gewichtsabnahme ist mit Semaglutid signifikant grösser als mit Liraglutid.
- Hemodynamic Changes in Response to GLP-1 Treatment in ICD and CRT Patients: Insights From HeartLogic Sensor Data.
- Liraglutide-mediated protection against ethanol-induced gastric ulcer in male and female rats: enhancement of mucosal defense, anti-inflammatory and antioxidant mechanism.
- Semaglutide ameliorates neuroinflammation and cognitive impairment in APP/PS1 mice.
- Unveiling the Hidden: Dissecting Liraglutide Oligomerization Dual Pathways via Direct Mass Technology, Electron-Capture Dissociation, and Molecular Dynamics.
- [Weight reducing and glucose reducing effects of liraglutide treatment for patients with type 2 diabetes].
- Association of semaglutide use with kidney outcomes in adults with ADPKD: A propensity score-matched real-world study.
- [Tirzepatide for heart failure with preserved ejection fraction (HFpEF) and obesity-the cardiometabolic turnaround?]
- Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study.
- Portal vein thrombosis in a patient on semaglutide.
- Improvement of Compulsive Shopping on Tirzepatide: A Case Report.
- Semaglutide Plus Low-Dose Metformin Combination Therapy for the Treatment of Obesity and Prediabetes in a Woman with Partial Deletion of the X Chromosome Long Arm.
- Semaglutide as a potential tool in pre-lung transplant weight loss optimization.
- Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes.
- DUAL GIP/GLP-1Ra reduces residual proteinuria in non-diabetic fabry disease.
- A glucose-responsive dual-nanoparticle-hydrogel-based microneedle patch for co-delivery of insulin and exendin-4.
- HMB and Liraglutide Confer Complementary Protection Against Lipotoxic and Atrophic Alterations in High-Glucose Plus Free Fatty Acid-Treated C2C12 Myotubes.
- Synthesis, Characterization, and Antidiabetic Evaluation of Sequence-Modified Liraglutide Analogs in a Drosophila melanogaster Model.
- Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis.
- Reply.
- Novo sets sights on obesity market with diabetes drug.
- A multimodal HPLC stability indicating approach for the estimation of Semaglutide and Tirzepatide in bulk, pharmaceutical dosage forms, and rat plasma: a six-edged sustainability appraisal.
- [Innovations in endocrinology and diabetology].
- Success story of GLP-1 agonist (Liraglutide) treatment in someone with type 1 diabetes: a life transformed.
- Liraglutide combined with routine therapy improves renal function, renal fibrosis, immune status, and prognosis of type 2 diabetes patients.
- Weekly Journal Scan: long-term effects of tirzepatide for diabetes prevention in persons with obesity and prediabetes.
- Tirzepatide Heralds the Hope of Chronic Disease Eradication.
- Exenatide Reduces Graft Injury in a Rat Transplantation Model Using Kidneys Donated after Cardiac Death.
- How would the use of Semaglutide impact the Chilean population? An estimated analysis following the SELECT trial approach.
- [Pharmacological and clinical profiles of a human GLP-1 analogue, liraglutide (Victoza(®))].
- Management of Hypoglycemia Using Continuous Glucose Monitoring During Tirzepatide Initiation or Uptitration When Used in Addition to Other Glucose-Lowering Agents.
- Metabolite Profiling and Identification of Semaglutide in Liver S9 Across Species and Rat Plasma.
- Tirzepatide-Induced Weight Loss and Normalization of Glycemia With Nerve Regeneration in Type 2 Diabetes: A Case Report.
- Once-Weekly Semaglutide in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Real-World Study.
- Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta-analysis.
- Sex-Specific and Reproductive Status-Dependent Effects of Liraglutide on Metabolic Disorders Associated with Prediabetes.
- Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence.
- Wernicke's Encephalopathy Following Semaglutide Treatment for Obesity: A Systematic PRISMA Review of Case-Based Evidence.
- Evaluating the Evolving Real-World Adverse Events of GLP-1RAs Using FDA Adverse Event Reporting System (FAERS).
- Semaglutide Modulates Visceral Adipose Tissue Lipid Metabolism in Type 2 Diabetic Mice: A Lipidomics Study.
- Glucagon-Like Peptide-1 Receptor Agonists as a Candidate Treatment for Opioid Use Disorder: From Rats to Humans.
- New combination therapy shows promise for recent-onset type 1 diabetes mellitus.
- Semaglutide restores metabolic and structural homeostasis along the gut-heart-metabolic axis in a cafeteria diet-induced obesity model.
- Boerhaave's syndrome associated with glucagon-like peptide-1 receptor agonist use: a case report.
- Septal GLP-1 receptors control alcohol taking and seeking.
- [The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].
- GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4.
- Liraglutide reduces the apoptosis of feeding and appetite-suppressing neurons in the hypothalamus of obese rats association with the PI3K/AKT/Foxo1 pathway.
- GLP-1 receptor agonists in ADPKD: from metabolic rationale to phenotype-enriched translational testing.
- The risk of retinal vascular events in patients using semaglutide: a scoping review.
- Incidence of Barrett's esophagus and esophageal cancer following sleeve gastrectomy versus liraglutide therapy.
- Glycemic, renal, and graft outcomes with dulaglutide versus multiple daily insulin therapy after kidney transplantation in type 2 diabetes.
- Association of Glucagon-Like Peptide-1 Receptor Agonists With Menstrual Events in Reproductive-Aged Patients.
- [Glucagon-like peptide-1 receptor agonists].
- Cardiovascular Effects of Glucagon Receptor Signaling Alone and Combined With Glucagon-Like Peptide-1 Receptor Signaling in Multiagonists: A Narrative Review With a Translational Focus.
- Tirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort study.
- [Medication or lifestyle for obesity? New medication is a wake-up call for the general practitioner].
- Liraglutide ameliorates diabetic lung injury and muscle damage via modulation of TLR4/NF-κB and Atrogin-1/AMPK signaling pathways.